NCT02129309View on ClinicalTrials.gov

Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
COPDPulmonary Hypertension
Interventions
PROCEDURE

Forearm plethysmography

Dose response study

PROCEDURE

Haemodynamic studies

Dose response study

Trial Locations (1)

CB2 0QQ

Vascular Research Unit, Clinical Pharmacology Unit, ACCI, Level 3, Addenbrooke's Hospital, Hills Road, Cambridge

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

collaborator

University of Cambridge

OTHER

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER

NCT02129309 - Haemodynamic Effects of Apelin Agonists and Antagonists in Man in COPD With Raised Pulmonary Artery Pressures | Biotech Hunter | Biotech Hunter